TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
PROK

ProKidney Corp.

Healthcare · Biotechnology

1.60$ +0.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

ProKidney Corp. (PROK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -120 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow PROK
Line item 2019 2020 2021 2022 2023 2024 2025
-0.1 -25 -50 -77 -90 -126 -120
0.0 1.0 2.0 3.0 3.9 5.4 6.6
0.0 0.7 0.7 74 31 29 25
0.5 0.7 0.7 74 – – –
0.0 -0.1 2.2 -6.5 17 4.0 1.3
0.0 5.5 5.2 1.8 34 30 15
0.0 -5.5 -5.2 -1.7 -330 20 104
– – 0.0 543 -9.5 0.0 0.0
0.0 0.0 0.0 0.0 -0.1 -0.1 0.0
0.0 20 71 549 -9.6 144 26
0.0 -11 16 470 -430 38 9.4
-0.1 -31 -55 -79 -124 -156 -135

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?